Industry Insight
Information, Observation & Analysis
Vaccines Articles
Approximately one million cases of shingles are reported annually in the U.S., and half of individuals over age 85 years are likely to develop shingles. The need for a vaccine that can provide protective immunity against shingles and PHN in older at-risk adults is clear.
Vaccination against these four specific diseases is recommended prior to travel to endemic areas.
Childhood vaccines are widely recognized as safe, but a growing minority of parents are choosing not have their children immunized.
Recent U.S. Food and Drug Administration advisory committee strain recommendations could make this season’s influenza (flu) vaccine more effective than ever. But, will an epidemic of public apathy undermine immunization efforts?
The efficacy of influenza (flu) vaccines has been greatly improved over the past several decades, but the flu virus still severely sickens hundreds of thousands of individuals each year. Is it possible that scientists have discovered a way to change that?
Influenza vaccination represents one of the most cost-effective treatment modalities available to the older adult population.
In the debate between personal freedom and government mandates, healthcare professionals are a reliable resource for vaccine information.
With an estimated 79 million Americans currently infected with HPV and an additional 14 million infections occurring each year, why are U.S. vaccination rates stagnantly low?
The measles resurgence is introducing a whole new generation of physicians to a once-eradicated
and potentially deadly disease.
Recent events have re-energized the ongoing debate about mandatory vaccines for children in the U.S. It remains to be seen which side of the controversy will prevail.
How do these infectious agents hitch a ride with passengers, and what role does screening play in containing the public health risk posed by international air travel?
While the anti-vaccine bandwagon is collapsing amid studies discrediting the link between vaccines and autism, public distrust remains. With some vaccine-preventable diseases reaching epidemic status, is it too late to turn the tide?